DORZICA E/DROP

DORZICA E/DROP is a combination ophthalmic solution containing dorzolamide 2% and timolol 0.5%. This dual-action medication is designed to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Dorzolamide works as a carbonic anhydrase inhibitor to decrease aqueous humor production, while timolol, a beta-blocker, further lowers eye pressure through multiple mechanisms. Together, these active ingredients provide enhanced therapeutic efficacy for managing elevated intraocular pressure. Administered as eye drops, DORZICA E/DROP offers convenient topical treatment. Suitable for patients who require combination therapy to achieve optimal pressure control. Always follow your healthcare provider's dosing instructions and consult before use if you have any underlying medical conditions or are taking other medications.